Deltakelse i radio eller TV

• Karl-Henning Kalland (2003). Diagnostikk av SARS-virus etablert i Bergen og Norge. (ekstern lenke)

Doktorgradsavhandling

• Waqas Azeem; Karl-Henning Kalland; Anne Margrete Øyan et al. (2018). Regulatory patterns in prostate cell differentiation – investigation of transcription factors AR, GATA2 and NKX3-1. (ekstern lenke)
• Jan Roger Olsen; Karl-Henning Kalland (2017). Context dependent transcription factor regulation in normal and malignant cell differentiation. (ekstern lenke)
• Karl-Henning Kalland (1989). Studies on measles virus in lytic and persistent infections ; Construction and use of measles virus specific nucleic acid probes. (ekstern lenke)

Fagbok

• G. Haukenes; Karl-Henning Kalland (1991). Kompendium i virologi. (ekstern lenke)
• [Mangler fornavn] Gravers; [Mangler fornavn] Wad; Atle Brun et al. (1989). Southeast Asia between Autocracy and Democracy. (ekstern lenke)

Forelesning

• Karl-Henning Kalland (2025). Enhanced dendritic cell-based cancer immunotherapy. (ekstern lenke)
• Karl Henning Kalland (2023). Drug Discovery and Development - CryoIT clinical trial updates. (ekstern lenke)
• Karl Henning Kalland (2022). Enhanced cryoimmunotherapy of urogenital cancers. (ekstern lenke)
• Karl Henning Kalland (2022). SARS-Cov-2 - virusevolusjon og immunrespons. (ekstern lenke)
• Karl Henning Kalland (2022). Cryoimmunterapi som ny kreftbehandling. (ekstern lenke)
• Karl Henning Kalland (2022). Cryoimmunterapi som ny kreftbehandling. (ekstern lenke)
• Karl Henning Kalland (2022). Enhanced cryoimmunotherapy against urogenital cancers. (ekstern lenke)
• Karl Henning Kalland (2022). Ny kreftbehandling i Bergen. (ekstern lenke)
• Karl Henning Kalland (2022). Cryoimmunterapi som ny kreftbehandling. (ekstern lenke)
• Karl Henning Kalland (2021). SARS-Cov-2 - virusevolusjon og immunrespons. (ekstern lenke)
• Karl Henning Kalland (2021). Virologisk evolusjon og immunrespons. (ekstern lenke)
• Karl Henning Kalland (2020). Utvikling og fremskritt i kreftforskning og kreftbehandling. (ekstern lenke)
• Karl-Henning Kalland (2007). Virus og kreft. (ekstern lenke)
• Karl-Henning Kalland; Ole Johan Halvorsen; Kari Rostad et al. (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. (ekstern lenke)

Forskningsrapport

• Lars Andreas Akslen; Karl Henning Kalland (2023). Annual Report 2022 Centre for Cancer Biomarkers. (ekstern lenke)
• Karl Henning Kalland (2022). CCBIO Annual Report 2022. (ekstern lenke)
• Karl Henning Kalland (2022). Cryoimmunotherapy - CryoIT Newsletter December 2022. (ekstern lenke)
• Karl Henning Kalland (2021). CCBIO Annual Report 2021. (ekstern lenke)
• Karl Henning Kalland (2021). Cryoimmunotherapy - CryoIT Newsletter December 2021. (ekstern lenke)

Fremhevet artikkel i media

• H. H. Samdal; Reinhardt W. Flø; G. Haukenes et al. (1993). HTLV-I-infeksjon i Norge. (ekstern lenke)

Kapittel i fagbok

• Waqas Azeem; Yaping Hua; Karl Henning Kalland et al. (2022). Models of Tumor Progression in Prostate Cancer. (ekstern lenke)
• Elling Ulvestad; Karl-Henning Kalland (2019). Hepatittvirus. (ekstern lenke)
• Karl-Henning Kalland; Øyvind Kommedal; Elling Ulvestad (2009). Molecular microbial diagnostics. (ekstern lenke)

Konferanseabstrakt

• Ingvild Løberg Tangen; Camilla Krakstad; Henrica Maria Johanna Werner et al. (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. (ekstern lenke)
• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (ekstern lenke)
• Jian Wang; Ecran Mutlu; Anne Margrete Øyan et al. (2011). TUMOR-ASSOCIATED GLIAL CELLS PROMOTE GROWTH OF GBM XENOGRAFTS IN EGFP NOD/SCID MICE. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Astrid Marta Olsnes et al. (2009). PRIMARY HUMAN ACUTE MYELOGENOUS LEUKEMIA CELLS SHOW CONSTITUTIVE RELEASE OF SEVERAL MATRIX METALLOPROTEASES AND THEIR INHIBITORS. (ekstern lenke)
• Camilla I Stapnes; Anita Ryningen; Kimberley Joanne Hatfield et al. (2007). Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in the susceptibility to histone deacetylase inhibitors. (ekstern lenke)
• Kimberley Joanne Hatfield; Randi Hovland; Anne Margrete Øyan et al. (2007). Release of angiopoietin-1 by acute myelogenous leukemia (AML) cells is increased by stromal cells and associated with mutations in the nucleophosmin (NPM) gene. (ekstern lenke)
• Camilla I Stapnes; Anita Ryningen; Kimberley Joanne Hatfield et al. (2007). Linking susceptibility to histone deactylase inhibitors and basal gene expression profiles in acute myeloid leukaemia. (ekstern lenke)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2006). ERG upregulation in relation to other transcription factors in prostate cancer. (ekstern lenke)
• Anne Margrete Øyan; Trond Hellem Bø; Inge Jonassen et al. (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. (ekstern lenke)
• Karl-Henning Kalland; Kari Rostad; Monica Mannelqvist et al. (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines. (ekstern lenke)
• Anne Margrete Øyan; Nina Ånensen; Trond Hellem Bø et al. (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. (ekstern lenke)
• Karl-Henning Kalland; Ole Johan Halvorsen; Kari Rostad et al. (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. (ekstern lenke)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2005). Single-minded 2 homolog gene is overexpressed in prostate cancer. (ekstern lenke)

Konferanseforedrag

• Karl Henning Kalland (2024). Cryoimmunotherapy (CryoIT) & Drug discovery and development. (ekstern lenke)
• Karl Henning Kalland (2024). Cryoimmunotherapy (CryoIT) - clinical trials of metastatic cancer. (ekstern lenke)
• Karl Henning Kalland (2023). Circulating tumor cell enumeration and ultradeep T-cell receptor-sequencing in a Phase I clinical trial of metastatic prostate cancer. (ekstern lenke)
• Karl Henning Kalland (2023). Cryoimmunotherapy (CryoIT) prinsipp og klinisk utprøving. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Lars Anders Rokne Reisæter et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC). (ekstern lenke)
• Seyed Mohammad Lellahi; Karl Henning Kalland (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function.. (ekstern lenke)
• Xisong Ke; Wencheng Li; Yi Qu et al. (2009). EMT Promotes Malignant Transformation of Prostate Epithelial Cells in Culture. (ekstern lenke)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Karl-Henning Kalland (2009). A novel cell culture model of prostate carcinogenesis and its utility in phenotypic screening of small molecular compounds. (ekstern lenke)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2008). Polycomb group target genes and bivalent H3K4 & K27me3 modifications in human embryonic cells were enriched among dysregulated genes in prostate cancer. (ekstern lenke)
• Karl-Henning Kalland (2008). Regulatory patterns of prostate carcinogenesis and development of a cell culture experimental system. (ekstern lenke)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2008). Epithelial to mesenchymal transition of a primary, immortalized prostate cell line is associated with gene expression switches of entire cell attachment modules. (ekstern lenke)
• Karl-Henning Kalland (2008). Targeting master regulatory mechanisms in cancer therapy using novel small molecular compounds – basic mechanisms, in vitro and in vivo screening and development towards the clinic. (ekstern lenke)
• Kari Rostad; Thorsten Schlomm; Svein Andreas Haukaas et al. (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients and identification of ERG target genes. (ekstern lenke)
• Xisong Ke; Anne Margrete Øyan; Kari Rostad et al. (2007). Functional oncogenomics and epigenomics analysis of prostate cancer. (ekstern lenke)
• Karl-Henning Kalland (2006). ERG upregulation in relation to other transcription factors in prostate cancer. (ekstern lenke)
• Anne Margrete Øyan; Nina Ånensen; Trond Hellem Bø et al. (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. (ekstern lenke)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2006). ERG upregulation and related transcription factors in prostate cancer. (ekstern lenke)
• Anne Margrete Øyan; Nina Ånensen; Trond Hellem Bø et al. (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. (ekstern lenke)
• Karl-Henning Kalland; Kari Rostad; Monica Mannelqvist et al. (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines. (ekstern lenke)
• Karl-Henning Kalland (2005). Onkogene, hepatotrope virus – molekylære mekanismer ved utvikling av hepatocellulært carcinom (HCC). (ekstern lenke)
• Cecile Perret-Vivancos; Janiasz Niedojadlo; Karl-Henning Kalland et al. (2005). Nuclear localization of active genes and their transcripts. (ekstern lenke)
• Karl-Henning Kalland (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. (ekstern lenke)
• Laila Stordrange; Anne Margrete Øyan; Bjørn Tore Gjertsen et al. (2005). Discovering candidate genes that distinguish between CML and AML using microarrays. (ekstern lenke)
• Karl-Henning Kalland; Ole Johan Halvorsen; Anne Margrete Øyan et al. (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue. (ekstern lenke)
• Karl-Henning Kalland (2004). Virus and cancer models. (ekstern lenke)
• Karl-Henning Kalland (2004). Real time quantitative PCR and hepatitis C monitoring. (ekstern lenke)
• Karl-Henning Kalland (2004). Global analysis of gene expression and regulatory modules in cancer tissue. (ekstern lenke)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2004). Gene expression profiles in prostate cancer: identification of upregulated SIM2 gene validated in archival tissue, relation to histological grading and prognosis. (ekstern lenke)
• Sue Olsen; Trond Hellem Bø; Kari Rostad et al. (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer. (ekstern lenke)
• Ole Johan Halvorsen; Anne Margrete Øyan; Trond Hellem Bø et al. (2003). Gene expression profiling in prostate cancer: cluster analysis and association with tumor differentation. (ekstern lenke)
• Ole J. Halvorsen; Anne Margrete Øyan; Trond Hellem Bø et al. (2003). Gene expression profiling in prostate cancer. (ekstern lenke)
• Karl-Henning Kalland (2003). Virus og Cancer. (ekstern lenke)
• Karl-Henning Kalland; Anne Margrete Øyan; Lars A. Akslen et al. (2003). Global analysis of gene expression and regulatory patterns in cancer. (ekstern lenke)
• Anne Margrete Øyan; Trond Hellem Bø; Inge Jonassen et al. (2003). Global analysis of gene expression and regulatory patterns in acute myeloid leukemia. (ekstern lenke)
• Karl-Henning Kalland; Ole J. Halvorsen; Anne Margrete Øyan et al. (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays. (ekstern lenke)
• Karl-Henning Kalland (2001). Global gene expression profiling using DNA microarrays - pitfalls and outlook. (ekstern lenke)
• Karl-Henning Kalland (2001). Global analysis of gene expression in human cancer. (ekstern lenke)
• Therese Visted; Tomasz Furmanek; Per Øystein Sakariassen et al. (2001). Angiostatin release from alginate encapsulated 293-cells. (ekstern lenke)

Konferanseposter

• Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2025). Early IDO-1 expression in activated DCs and the positive feedback response to IDO-1 Inhibitors. (ekstern lenke)
• Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2024). Regulation of IDO1 in Human Dendritic Cells: Implications for Cancer Immunotherapy.. (ekstern lenke)
• Yaping Hua; Yuan Xing; Yunheng Shen et al. (2024). Potential of propionyl cinobufagin for the treatment of castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC). (ekstern lenke)
• Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2024). Regulation of IDO1 in Human Dendritic Cells: Implications for Cancer Immunotherapy. (ekstern lenke)
• Andreas Tvedt Skarstein; Tuyen Hoang; Hallvard Haugen et al. (2023). In vitro Study of STAT3-inhibitors in Drug-Resistant Chronic Myeloid Leukemia (CML). (ekstern lenke)
• Waqas Azeem; Mohammad Lellahi; Yaping Hua et al. (2023). IDO-1 regulation in human dendritic cells. (ekstern lenke)
• Yaping Hua; Yuan Xing; Yunheng Shen et al. (2023). Potential of propionyl cinobufagin for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and neuroendocrine prostate cancer (NEPC). (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Lars Anders Rokne Reisæter et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC). (ekstern lenke)
• Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2023). Regulation of Indoleamine dioxygenase 1 in human dendritic cells. (ekstern lenke)
• Yaping Hua; Yuan Xing; Yunheng Shen et al. (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization. (ekstern lenke)
• Seyed Mohammad Lellahi; Waqas Azeem; Yaping Hua et al. (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function. (ekstern lenke)
• Waqas Azeem; Seyed Mohammad Lellahi; Yaping Hua et al. (2022). Robust and potent dendritic cells for cancer immunotherapy. (ekstern lenke)
• Yaping Hua; Yuan Xing; Yunheng Shen et al. (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization. (ekstern lenke)
• Waqas Azeem; Mohammad Lellahi; Yaping Hua et al. (2022). Robust production of potent dendritic cells for cancer immunotherapy. (ekstern lenke)
• Yi Qu; Run-hui Liu; Jigang Zhang et al. (2013). Reactive oxygen species induce prostate cancer cells via activation of the IL6/STAT3 pathway. Abstract 304. (ekstern lenke)
• Jan Roger Olsen; Anne Margrete Øyan; Kari Rostad et al. (2013). TP63 regulation of EMT in an experimental prostate cell model. (ekstern lenke)
• Oddbjørn Straume; Takeshi Shimamura; Anne Margrete Øyan et al. (2009). Suppression of heat shock Protein 27 induces long-term dormancy in human breast cancer. (ekstern lenke)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2009). Epithelial to mesenchymal transition of a primary prostate cell line before malignant transformation with switches of cell adhesion modules. (ekstern lenke)
• Xisong Ke; Yi Qu; Varder Rotter et al. (2009). Global profiling of histone and DNA methylation reveals epigenetic-based gene regulation during EMT and transformation in a prostate cell model. (ekstern lenke)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (ekstern lenke)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2009). A novel model of stepwise prostate carcinogenesis in culture. (ekstern lenke)
• Xisong Ke; Yi Qu; Varder Rotter et al. (2009). Global profiling of histone and DNA methylation reveals epigenetic-based gene regulation during EMT and transformation in a prostate cell model. (ekstern lenke)
• Ingrid Moen; Anne Margrete Øyan; Karl-Henning Kalland et al. (2009). Hyperoxic Treatment induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model. (ekstern lenke)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Tor-Christian Aase Johannessen; Jian Wang; Kai Ove Skaftnesmo et al. (2009). Highly infiltrative brain tumors show reduced chemosensitivity associated with a stem cell-like phenotype. (ekstern lenke)
• Xisong Ke; Wencheng Li; Yi Qu et al. (2009). Stepwise prostate carcinogenesis in vitro culture. (ekstern lenke)
• Xisong Ke; Yi Qu; Ole Johan Halvorsen et al. (2008). Polycomb (PcG) targets are enriched in repressed genes in prostate cancer. (ekstern lenke)
• Monica Mannelqvist; Trond Hellem Bø; Geir Bredholt et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (ekstern lenke)
• Kari Rostad; Thorsten Schlomm; Svein Andreas Haukaas et al. (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients. (ekstern lenke)
• Anne Margrete Øyan; Nina Ånensen; Trond Hellem Bø et al. (2007). Early gene expression signature of chemotherapy treated acute myeloid leukemia in vivo. (ekstern lenke)
• Monica Mannelqvist; Trond Hellem Bø; Geir Bredholt et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (ekstern lenke)
• Håvard Valvatne; Ruth M Støbakk Stavrum; Sabai Phyu et al. (2006). Identification of deletions in clinical Mycobacterium tuberculosis isolates using comparative genomic hybridisation. (ekstern lenke)
• Ruth M Støbakk Stavrum; Håvard Valvatne; Anne-Kristin Stavrum et al. (2006). Dynamics of global macrophage expression responses to in vitro infection with wild-type and a hypervirulent mce1-mutant of M. tuberculosis. (ekstern lenke)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2006). Single-minded 2 homolog (SIM2) is overexpressed in prostate cancer. (ekstern lenke)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2006). ERG upregulation in relation to other transcription factors in prostate cancer. (ekstern lenke)
• Anne Margrete Øyan; Trond Hellem Bø; Inge Jonassen et al. (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. (ekstern lenke)
• Helga Salvesen; Trond Hellem Bø; Ingunn Marie Stefansson et al. (2006). Gene expression profiles identify an aggressive phenotype in endometrial carcinoma. (ekstern lenke)
• Karl-Henning Kalland; Ole Johan Halvorsen; Monica Mannelqvist et al. (2005). ETS transcription factors in prostate cancer. (ekstern lenke)
• Trond Hellem Bø; Laila Stordrange; Anne Margrete Øyan et al. (2005). Analysis of treatment response in acute myeloid leukemia patients using DNA microarrays. (ekstern lenke)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2005). Single-minded 2 homolog gene (SIM2) is overexpressed in prostate cancer. (ekstern lenke)
• Karl-Henning Kalland; Ole Johan Halvorsen; Kari Rostad et al. (2005). Very high expression of specific transcription factors in prostate cancer compared with paired benign prostate tissue. (ekstern lenke)
• Harleen Grewal; Håvard Valvatne; Karl-Henning Kalland et al. (2004). Detection of common agents of bacterial meningitis with a low density DNA array. (ekstern lenke)
• Karl-Henning Kalland; Ole J. Halvorsen; Anne Margrete Øyan et al. (2003). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue. (ekstern lenke)
• Dusan Cmarko; Stig Ove Bøe; Catia Scasselati et al. (2001). Rev inhibition and nucleocytoplasmic transport of HIV RNAs. (ekstern lenke)

Leserbrev

• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2010). Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. (ekstern lenke)

Masteroppgave

• Karl Henning Kalland; Ragnhild Bakke; Ragnhild Maukon Bakke (2021). Dendritic cells for immunotherapy. (ekstern lenke)
• Sue Olsen; Karl-Henning Kalland; Anders Fjose (2005). DNA microarray and real time quantitative PCR analysis of gene expression in prostate tissues and cancer Optimisation,validation and specific gene expression. (ekstern lenke)

Medieintervju

• Karl-Henning Kalland (2013). Til hjelp for andre i 40 år - Tordis og Fritz C. Riebers legat 1973 - 2013. (ekstern lenke)
• Karl-Henning Kalland (2013). Legat-jubileum: midler til kreftforskning. (ekstern lenke)
• Karl-Henning Kalland (2013). Omprogrammerer celler - utforsker nye angrepsmål ved prostatakreft. (ekstern lenke)
• Karl-Henning Kalland (2013). Skreddersyr medisiner mot kreft. (ekstern lenke)
• Karl-Henning Kalland (2008). Bergens Tidende - Vil ha DNA-lab i Bergen. (ekstern lenke)
• Karl-Henning Kalland (2008). Verdens Gang - Professorat betalt av GlaxoSmithKline ved Universitetet i Bergen. (ekstern lenke)
• Karl-Henning Kalland; Pernille Dysthe (2007). Livmorhalskreft. (ekstern lenke)
• Karl-Henning Kalland; Gudrun Vinsrygg (2005). Legionella og andre bakterier. (ekstern lenke)
• Karl-Henning Kalland; Anne Lise Spissøy (2005). Gades Institutt - presentasjon. (ekstern lenke)
• Karl-Henning Kalland; Lars Petter Gallefoss (2005). Gades Institutt - presentasjon. (ekstern lenke)
• Karl-Henning Kalland; Gudrun Vinsrygg (2003). Bakterier og virus - slik beskytter du deg. (ekstern lenke)
• Karl-Henning Kalland (2001). Bakterier og virus. (ekstern lenke)

Populærvitenskapelig artikkel

• Karl Brokstad; Karl-Henning Kalland (1998). HIV som modellsystem til forståing av genekspresjon. (ekstern lenke)

Tidsskriftomtale

• Karl-Henning Kalland (2007). Immunologiske refleksjonar - "Defending Life" av Elling Ulvestad, London - Springer forlag ISBN 978-1-4020-5675-8. (ekstern lenke)

Vitenskapelig artikkel

• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Bjørn Tore Gjertsen et al. (2023). A prospective non-randomized phase I trial of dendritic cell–based cryoimmunotherapy combined with checkpoint inhibitors in mCRPC.. (ekstern lenke)
• Seyed Mohammad Lellahi; Waqas Azeem; Yaping Hua et al. (2023). GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Lars Anders Rokne Reisæter et al. (2023). A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer. (ekstern lenke)
• Yaping Hua; Xing Yuan; Yun-Heng Shen et al. (2022). Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain. (ekstern lenke)
• Waqas Azeem; Jan Roger Olsen; Margrete Reime Hellem et al. (2022). Proteasome‐mediated regulation of GATA2 expression and androgen receptor transcription in benign prostate epithelial cells. (ekstern lenke)
• Waqas Azeem; Ragnhild Maukon Bakke; Benjamin Gabriel et al. (2021). Evaluation of β-catenin inhibition of axitinib and nitazoxanide in human monocyte-derived dendritic cells. (ekstern lenke)
• Waqas Azeem; Ragnhild Maukon Bakke; Silke Appel et al. (2020). Dual pro- and anti-inflammatory features of monocyte-derived dendritic cells. (ekstern lenke)
• Frederik Holst; Henrica Maria Johanna Werner; Siv Mjøs et al. (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. (ekstern lenke)
• Aril Løge Håvik; Ove Bruland; Mads Aarhus et al. (2018). Screening for viral nucleic acids in vestibular schwannoma. (ekstern lenke)
• Kanthida Kusonmano; Mari Kyllesø Halle; Elisabeth Wik et al. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. (ekstern lenke)
• Yaping Hua; Waqas Azeem; Yunheng Shen et al. (2018). Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. (ekstern lenke)
• Yi Qu; Jan Roger Olsen; Xing Yuan et al. (2018). Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer. (ekstern lenke)
• Lina Wik Leiss; Ercan Mutlu; Anne Margrete Øyan et al. (2017). Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. (ekstern lenke)
• Karen Klepsland Mauland; Zhenlin Ju; Ingvild Løberg Tangen et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (ekstern lenke)
• Mari Kyllesø Halle; Ingvild Løberg Tangen; Hege Fredriksen Berg et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (ekstern lenke)
• Waqas Azeem; Margrete Reime Hellem; Jan Roger Olsen et al. (2017). An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells. (ekstern lenke)
• Siv Mjøs; Henrica Maria Johanna Werner; Even Birkeland et al. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. (ekstern lenke)
• Ingvild Løberg Tangen; Therese Bredholt Onyango; Reidun Kristin Kopperud et al. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. (ekstern lenke)
• Jorunn Litlekalsøy; Kari Rostad; Karl-Henning Kalland et al. (2016). Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes. (ekstern lenke)
• Jan Roger Olsen; Waqas Azeem; Margrete Reime Hellem et al. (2016). Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. (ekstern lenke)
• Karen Klepsland Mauland; Elisabeth Wik; Erling Andre Høivik et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (ekstern lenke)
• Yi Qu; Naouel Gharbi; Xing Yuan et al. (2016). Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer. (ekstern lenke)
• Ingunn Stefansson; Maria B Ræder; Elisabeth Wik et al. (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. (ekstern lenke)
• Anna Berg; Erling Andre Høivik; Siv Mjøs et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (ekstern lenke)
• Geir Bredholt; Monica Mannelqvist; Ingunn Stefansson et al. (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. (ekstern lenke)
• Camilla Krakstad; Ingvild Løberg Tangen; Erling Andre Høivik et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (ekstern lenke)
• Erling Andre Høivik; Kanthida Kusonmano; Mari Kyllesø Halle et al. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. (ekstern lenke)
• Michael S. Rogers; Katherine Novak; David Zurakowski et al. (2014). Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. (ekstern lenke)
• Elisabeth Wik; Jone Trovik; Kanthida Kusonmano et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (ekstern lenke)
• Hilde Renate Haugen Engerud; Ingvild Løberg Tangen; Ansgar Berg et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (ekstern lenke)
• Ingvild Løberg Tangen; Camilla Krakstad; Mari Kyllesø Halle et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (ekstern lenke)
• Yi Qu; Wencheng Li; Margrete Reime Hellem et al. (2013). MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. (ekstern lenke)
• Jan Roger Olsen; Anne Margrete Øyan; Kari Rostad et al. (2013). p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. (ekstern lenke)
• Henrica Maria Johanna Werner; Anna Berg; Elisabeth Wik et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (ekstern lenke)
• Håkon Reikvam; Anne Margrete Øyan; Karl-Henning Kalland et al. (2013). Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients. (ekstern lenke)
• Yi Qu; Anne Margrete Øyan; Run-hui Liu et al. (2013). Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. (ekstern lenke)
• Elisabeth Wik; Even Birkeland; Jone Trovik et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (ekstern lenke)
• Elisabeth Wik; Maria B Ræder; Camilla Krakstad et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (ekstern lenke)
• Maria B Ræder; Even Birkeland; Jone Trovik et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (ekstern lenke)
• Kjell Petersen; Uros Rajcevic; Siti Aminah Abdul Rahim et al. (2013). Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model. (ekstern lenke)
• Camilla Krakstad; Jone Trovik; Elisabeth Wik et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (ekstern lenke)
• Camilla Krakstad; Even Birkeland; Danila Seidel et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. (ekstern lenke)
• Even Birkeland; Elisabeth Wik; Siv Mjøs et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (ekstern lenke)
• Oddbjørn Straume; Takeshi Shimamura; Michael J.G. Lampa et al. (2012). Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. (ekstern lenke)
• Monica Mannelqvist; Ingunn Marie Stefansson; Elisabeth Wik et al. (2012). Lipocalin 2 expression is associated with aggressive features of endometrial cancer. (ekstern lenke)
• Ingrid Moen; Alison Charlotte Jevne; Jian Wang et al. (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. (ekstern lenke)
• Monica Mannelqvist; Ingunn Marie Stefansson; Geir Bredholt et al. (2011). Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer. (ekstern lenke)
• Janusz Niedojadlo; Cecile Perret-Vivancos; Karl-Henning Kalland et al. (2011). Transcribed DNA is preferentially located in the perichromatin region of mammalian cell nuclei. (ekstern lenke)
• Yuval Tabach; Ira Kogan-Sakin; Yosef Buganim et al. (2011). Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. (ekstern lenke)
• Karen Klepsland Mauland; Jone Trovik; Elisabeth Wik et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (ekstern lenke)
• Xisong Ke; Wencheng Li; Randi Hovland et al. (2011). Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. (ekstern lenke)
• Xisong Ke; Yi Qu; Yang Cheng et al. (2010). Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Anne Margrete Øyan et al. (2010). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. (ekstern lenke)
• Håkon Reikvam; Kimberley Joanne Hatfield; Anne Margrete Øyan et al. (2009). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors; release profile and pharmacological modulaion. (ekstern lenke)
• Ingrid Moen; Anne Margrete Øyan; Karl-Henning Kalland et al. (2009). Hyperoxic treatment induces mesenchymal to epithelial transition in a rat adenocarcinoma model. (ekstern lenke)
• Kari Rostad; Olaf JC Hellwinkel; Svein Andreas Haukaas et al. (2009). TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. (ekstern lenke)
• Anne Margrete Øyan; Nina Ånensen; Trond Hellem Bø et al. (2009). Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. (ekstern lenke)
• Bengt Åge Sørby Borge; Karl-Henning Kalland; Sue Olsen et al. (2009). Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. (ekstern lenke)
• Kimberley Joanne Hatfield; Anne Margrete Øyan; Elisabeth Ersvær et al. (2009). Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia. (ekstern lenke)
• Kimberley Joanne Hatfield; Anne Margrete Øyan; Elisabeth Ersvær et al. (2009). Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators. (ekstern lenke)
• Helga Birgitte Salvesen; Scott L. Carter; Monica Mannelqvist et al. (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (ekstern lenke)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Tor-Christian Aase Johannessen; Jian Wang; Kai Ove Skaftnesmo et al. (2009). Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. (ekstern lenke)
• Biaoyang Lin; Angelita G. Utleg; Karsten Gravdal et al. (2008). WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence. (ekstern lenke)
• Ingeborg Bøe Engelsen; Monica Mannelqvist; Ingunn Marie Stefansson et al. (2008). Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. (ekstern lenke)
• Kimberley Joanne Hatfield; Randi Hovland; Anne Margrete Øyan et al. (2008). Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. (ekstern lenke)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2008). Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation. (ekstern lenke)
• Camilla I Stapnes; Anita Ryningen; Kimberley Joanne Hatfield et al. (2007). Functional characteristics and gene expression profiles of primary acute myeloid leukamia cells indentify patient subgroups that differ susceptibility to histone deactylase inhibitors. (ekstern lenke)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2007). Increased expression of sim2-s protein is a novel marker of aggressive prostate cancer. (ekstern lenke)
• Linda Elin Birkhaug Stuhr; Anette Bjaaland Raa; Anne Margrete Øyan et al. (2007). Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. (ekstern lenke)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2007). ERG upregulation and related ETS transcription factors in prostate cancer. (ekstern lenke)
• Øystein Bruserud; Anita Ryningen; Astrid Marta Olsnes et al. (2007). Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. (ekstern lenke)
• Kjell Petersen; Anne Margrete Øyan; Kari Rostad et al. (2007). Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. (ekstern lenke)
• Anne Margrete Øyan; Trond Hellem Bø; Inge Jonassen et al. (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. (ekstern lenke)
• Nina Ånensen; Anne Margrete Øyan; Jean-Christophe Bourdon et al. (2006). A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. (ekstern lenke)
• Anita Ryningen; Elisabeth Ersvær; Anne Margrete Øyan et al. (2006). Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2 : Bax ratio and low levels of heat shock protein 70 and 90. (ekstern lenke)
• Per Øystein Sakariassen; Lars Prestegarden; Jian Wang et al. (2006). Angiogenesis-independent tumor growth mediated by stem-like cancer cells. (ekstern lenke)
• Anne Margrete Øyan; Trond Hellem Bø; Inge Jonassen et al. (2005). CD34 expression in native human acute myelogenous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles. (ekstern lenke)
• Ole Johan Halvorsen; Anne Margrete Øyan; Trond Hellem Bø et al. (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. (ekstern lenke)
• Karl-Henning Kalland; Helge Myrmel; Svein Arne Nordbø (2005). Nukleinsyrediagnostikk i medisinsk mikrobiologi. (ekstern lenke)
• Cathrine Husberg; Paula Murphy; E Bjorgo et al. (2003). Cellular localisation and nuclear export of the human bZIP transcription factor TCF11. (ekstern lenke)
• Dusan Cmarko; Stig Ove Bøe; Cati Scassellati et al. (2002). Rev inhibition strongly affects intracellular distribution of HIV-1 RNAs. (ekstern lenke)
• Bjørn Tore Gjertsen; Anne Margrete Øyan; Bruz Marzolf et al. (2002). Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analyses. (ekstern lenke)
• Bodil Bjørndal; Charlotte Helleland; Stig Ove Bøe et al. (2002). Nuclear import of factors involved in signaling is inhibited in C3H/10T1/2 cells treated with tetradecylthioacetic acid. (ekstern lenke)
• Karl Albert Brokstad; Karl-Henning Kalland; William C. Russell et al. (2001). Mitochondrial protein p32 can accumulate in the nucleus. (ekstern lenke)
• Stig Ove Bøe; Karl-Henning Kalland (2000). Identification of a nuclear ribonucleoprotein particle which contains incompletely spliced HIV-1 RNAs. (ekstern lenke)
• Anne Marie Szilvay; Stig Ove Bøe; Karl-Henning Kalland (1999). A trans-dominant negative mutant of the HIV-1 Rev protein affects the Rev-dependent splicing pattern and expression of HIV RNA. (ekstern lenke)
• Karl-Henning Kalland; Gunnar Haukenes (1999). Nukleinsyrebasert mikrobiolgoisk diagnostikk. (ekstern lenke)
• Anne Marie Szilvay; Stig Ove Bøe; Karl-Henning Kalland (1999). Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs. (ekstern lenke)
• Gunnar Haukenes; Karl-Henning Kalland (1998). Visualisation of ribosomal RNA (rRNA) synthesis in eukaryotic cells in culture. (ekstern lenke)
• Stig Ove Bøe; AM Szilvay; Karl-Henning Kalland (1998). Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and the splicing factor SC-35. (ekstern lenke)
• A Kanestrøm; V Andresen; AM Szilvay et al. (1998). Histographic recording of human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev and nuclear factors. (ekstern lenke)
• Gunnar Haukenes; Karl-Henning Kalland (1998). Labelling of eukaryotic RNA transcripts with BrUTP using liposomal (DOTAP) and non-liposomal (FuGENE 6) transfection reagents: new application for transfection reagents. (ekstern lenke)
• Anne Marie Szilvay; K. A. Brokstad; Stig Ove Bøe et al. (1997). Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. (ekstern lenke)
• Gunnar Haukenes; Anne Marie Szilvay; K. A. Brokstad et al. (1997). Labelling of RNA transcripts of eukaryotic cells in culture with Br UTP using a liposome transfection reagent (DOTAP). (ekstern lenke)
• May Britt Kalvenes; Karl-Henning Kalland; G. Haukenes (1996). Immunoglobin G sublass antibodies to rubella viruses in chronic liver disease, acute rubella and healthy controls. (ekstern lenke)
• C. Holm-Hansen; S. Ayehunie; B. Johansson et al. (1996). HIV-1 proviral DNA sequences of env PCR amplificates from Tanzania. (ekstern lenke)
• May Britt Kalvenes; G Haukenes; G Nysæter et al. (1995). Raised levels of antibodies to human viruses at the clinical onset of autoimmune chronic active hepatitis. (ekstern lenke)
• AM Szilvay; KA Brokstad; R Kopperud et al. (1995). Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. (ekstern lenke)
• May Britt Kalvenes; Karl-Henning Kalland; G. Haukenes (1994). Radioimmunoprecipitation and immunoblot studies of antibodies to rubella virus in patients with chronic liver disease. (ekstern lenke)
• G. Haukenes; B. Viggen; B. Boye et al. (1994). Viral antibodies in infectious mononucleosis. (ekstern lenke)
• May Britt Kalvenes; Karl-Henning Kalland; G. Haukenes (1994). Elevated rubella antibodies in patients with chronic liver diseases. (ekstern lenke)
• Reinhardt W. Flø; H. H. Samdal; Karl-Henning Kalland et al. (1993). Diagnosis of infection with human T-cell lymphotropic virus type 2 (HTL V-2) in Norwegian HIV infected individuals. (ekstern lenke)
• E. L. Langhoff; E. Terwillinger; H. J. Bos et al. (1991). Replication of HIV-1 in primary dendritic cell cultures. (ekstern lenke)
• Karl-Henning Kalland; May Britt Kalvenes; A. M. Øyan et al. (1991). Study of transcription in measles virus infected Vero cells using cDNA probes prepared from poly(A)RNA from uninfected and infected cells. (ekstern lenke)
• Karl-Henning Kalland; May Britt Kalvenes; G. Haukenes (1991). Viral RNA species in cell lines persistently and lytically infected with measles virus. (ekstern lenke)
• Karl-Henning Kalland; E. L. Langhoff; H. J. Bos et al. (1991). Rex-dependent nucleolar accumulation of HTLV-1 mRNA. (ekstern lenke)
• Halvor Sommerfelt; Harleen Grewal; W. Gaastra et al. (1991). Presence of cfaD-homologous sequences and expression of coli surface antigen 4 on enterotoxigenic Escherichia coli; relevance for diagnostic procedures. (ekstern lenke)
• Catrine Albretsen; Karl-Henning Kalland; Bjørn Ivar Haukanes et al. (1990). Applications of Magnetic Beads With Covalently Attached Oligonucleotides in Hybridization: Isolation and Detection of Specific Measles Virus mRNA from Crude Cell Lysate. (ekstern lenke)
• Halvor Sommerfelt; Bjørn Ivar Haukanes; Karl-Henning Kalland et al. (1989). Mechanism of spontaneous loss of heat-stable toxin (STa) Production in enterotoxigenic Escherichia coli. (ekstern lenke)
• Halvor Sommerfelt; Ann-Mari Svennerholm; Karl-Henning Kalland et al. (1988). Comparative Study of Colony Hybridization With Synthetic Oligonucleotide Probes and Enzyme-Linked Immunosorbent Assay for Identification of Enterotoxigenic Escherichia Coli. (ekstern lenke)

Vitenskapelig bokkapittel

• Waqas Azeem; Yaping Hua; Karl-Henning Kalland et al. (2017). Models of Tumor Progression in Prostate Cancer. (ekstern lenke)
• Karl-Henning Kalland (2009). Molecular Microbiological Diagnostics. (ekstern lenke)
• Gunnar Haukenes; Karl-Henning Kalland; Eva Birgitta Åsjø et al. (1998). Mikrobiologisk diagnostikk. Kapittel om Nukleinsyrebasert diagnostikk. (ekstern lenke)
• Karl-Henning Kalland; E. L. Langhoff; H. J. Bos et al. (1991). Retroviral regulatory proteins and the nucleolus. (ekstern lenke)
• E. L. Langhoff; E. Terwillinger; Karl-Henning Kalland et al. (1991). HIV-1 infection of human dendritic cells. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Oddmund Nordgård; Rakel Brendsdal Forthun; Morten Lapin et al. (2021). Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System. (ekstern lenke)
• Bojun Wang; Tian Tian; Karl-Henning Kalland et al. (2018). Targeting Wnt/β-catenin signaling for cancer immunotherapy. (ekstern lenke)
• Karl-Henning Kalland; Xisong Ke; Anne Margrete Øyan (2009). Tumor virology - history, status and future challenges. (ekstern lenke)
• Nina Ånensen; Anne Margrete Øyan; Sjur Huseby et al. (2007). Early gene expression of acute myeloid leukemia in response to chemotherapy. (ekstern lenke)
• Anne Margrete Øyan; Trond Hellem Bø; Inge Jonassen et al. (2007). Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in Acute Myeloid Leukemia. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.